Cerebral perfusion in the predementia stages of Alzheimer’s disease

European Radiology

Volumn 26, Issue 2, 2016, Pages 506-514

  Binnewijzend, Maja A A ^a   Benedictus, Marije R ^a   Kuijer, Joost P A ^a   van der Flier, Wiesje M ^a   Teunissen, Charlotte E ^a   Prins, Niels D ^a   Wattjes, Mike P ^a   van Berckel, Bart N M ^a   Scheltens, Philip ^a   Barkhof, Frederik ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer s disease; Arterial spin labelling MRI; Cerebral blood flow cerebral perfusion; Disease progression; Prodromal AD

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN; SPIN LABEL;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CEREBELLUM; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; FRONTAL LOBE; HUMAN; IMAGE PROCESSING; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL LOBE; PARIETAL LOBE; POSTERIOR CINGULATE; PRECUNEUS; PREDEMENTIA; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; TEMPORAL LOBE; THREE DIMENSIONAL IMAGING; BRAIN CIRCULATION; FEMALE; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

AGED; ALZHEIMER DISEASE; CEREBROVASCULAR CIRCULATION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SPIN LABELS;

EID: 84954365564     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-015-3834-9     Document Type: Article

References (34)

1. Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS et al (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 132:1355–1365
2. Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, Reiman EM et al (2009) Relationships between biomarkers in aging and dementia. Neurology 73:1193–1199
3. Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW et al (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9:119–128
4. Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS et al (2013) Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12:207–216
5. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:270–279
6. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:263–269
7. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM et al (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:280–292
8. Binnewijzend MA, Kuijer JP, Benedictus MR, van der Flier WM, Wink AM, Wattjes MP et al (2013) Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology 267:221–230
9. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939–944
10. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST (2001) Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56:1133–1142
11. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256:183–194
12. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 149:351–356
13. Dai W, Garcia D, de BC, Alsop DC (2008) Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 60:1488–1497
14. Alsop DC, Detre JA, Golay X, Gunther M, Hendrikse J, Hernandez-Garcia L et al (2014) Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med. doi:10.1002/mrm.25197
15. Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR (1998) A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 40:383–396
16. Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17:143–155
17. Jenkinson M, Smith S (2001) A global optimisation method for robust affine registration of brain images. Med Image Anal 5:143–156
18. Zhang Y, Brady M, Smith S (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20:45–57
19. Asllani I, Borogovac A, Brown TR (2008) Regression algorithm correcting for partial volume effects in arterial spin labeling MRI. Magn Reson Med 60:1362–1371
20. Mulder C, Verwey NA, van der Flier WM, Bouwman FH, Kok A, van Elk EJ et al (2010) Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clin Chem 56:248–253
21. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM (2009) Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 250:856–866
22. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ et al (2005) Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 234:851–859
23. Bangen KJ, Restom K, Liu TT, Wierenga CE, Jak AJ, Salmon DP et al (2012) Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study. J Alzheimers Dis 31(Suppl 3):S59–S74
24. Chao LL, Buckley ST, Kornak J, Schuff N, Madison C, Yaffe K et al (2010) ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord 24:19–27
25. Fleisher AS, Podraza KM, Bangen KJ, Taylor C, Sherzai A, Sidhar K et al (2009) Cerebral perfusion and oxygenation differences in Alzheimer's disease risk. Neurobiol Aging 30:1737–1748
26. Kim SM, Kim MJ, Rhee HY, Ryu CW, Kim EJ, Petersen ET et al (2013) Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele. Neuroradiology 55:25–34
27. Binnewijzend MA, Kuijer JP, van der Flier WM, Benedictus MR, Moller CM, Pijnenburg YA et al (2014) Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies. Eur Radiol 24:2326–2333
28. Fong TG, Inouye SK, Dai W, Press DZ, Alsop DC (2011) Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction? Brain Imaging Behav 5:25–35
29. Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6:67–77
30. Chen Y, Wolk DA, Reddin JS, Korczykowski M, Martinez PM, Musiek ES et al (2011) Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology 77:1977–1985
31. Jueptner M, Weiller C (1995) Review: does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI. Neuroimage 2:148–156
32. Musiek ES, Chen Y, Korczykowski M, Saboury B, Martinez PM, Reddin JS et al (2012) Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. Alzheimers Dement 8:51–59
33. Grimmer T, Faust M, Auer F, Alexopoulos P, Forstl H, Henriksen G et al (2012) White matter hyperintensities predict amyloid increase in Alzheimer's disease. Neurobiol Aging 33:2766–2773
34. Campbell AM, Beaulieu C (2006) Pulsed arterial spin labeling parameter optimization for an elderly population. J Magn Reson Imaging 23:398–403